IRVINE, Calif. — Edwards Lifesciences Corp. on Tuesday reported worse-than-expected sales for the third quarter and forecast another shortfall in the fourth quarter, sending its shares down in after-hours trading. The company said it earned $141.4 million, or 65 cents per share, during the quarter, up 20 percent from $118.1 million, or 54 cents per
